<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02141737</url>
  </required_header>
  <id_info>
    <org_study_id>20140514</org_study_id>
    <nct_id>NCT02141737</nct_id>
  </id_info>
  <brief_title>Effect of Pre-injection of Lidocaine on Myoclonus Induced by Induction With Etomidate in Elderly Patients During General Anesthesia</brief_title>
  <official_title>Effect of Pre-injection of Lidocaine on Myoclonus Induced by Induction With Etomidate in Elderly Patients During General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tang-Du Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effect of pre-injection of lidocaine on myoclonus induced by induction with
      etomidate during general anesthesia in elderly patients
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>severity of myoclonus induced by</measure>
    <time_frame>90 seconds from the beginning of etomidate injection</time_frame>
    <description>myoclonic movements are graded as 0=no myoclonus, 1=mild myoclonus (short movement of a body segment e.g., a finger or a wrist), 2=moderate myoclonus (mild movement of two different muscle groups e.g., face and arm), or 3=severe myoclonus (intense myoclonic movement in two or more muscle groups, fast adduction of a limb)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>intensity of injection pain</measure>
    <time_frame>during the injection of etomidate, expected to be within 1 minutes</time_frame>
    <description>The intensity of pain was graded using a verbal rating scale. 0-None (negative response to questioning)
Mild pain (pain reported only in response to questioning without any behavioral signs)
Moderate pain (pain reported in response to questioning and accompanied by a behavioral sign or pain reported spontaneously without questioning)
Severe pain (strong vocal response or response accompanied by facial grimacing, arm withdrawl or tears)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hemodynamic parameters after injection of etomidate</measure>
    <time_frame>baseline to 2 minutes after injetion of etomidate</time_frame>
    <description>Heart rate and mean arterial pressure will be recorded before induction, before the injection of etomidate, 1 minute and 2 minutes after injection of etomidate</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">272</enrollment>
  <condition>General Anesthesia</condition>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Induction protocol: patients will be given 2 ml normal saline solution, 1 minutes later, 0.3 mg/kg etomidate is injected within 30 to 60 s, and 90 s after the injection of etomidate, 0.2 mg/kg midazolam, 3 μg/kg fentanyl, 0.6 mg/kg rocuronium are given sequently.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group L1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Induction protocol: patients will be given 2 ml diluted lidocaine injection in which 20 mg lidocaine is contained, 1 minutes later, 0.3 mg/kg etomidate is injected within 30 to 60 s, and 90 s after the injection of etomidate, 0.2 mg/kg midazolam, 3 μg/kg fentanyl, 0.6 mg/kg rocuronium are given sequently.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group L2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Induction protocol: patients will be given 2 ml diluted lidocaine injection in which 30 mg lidocaine is contained, 1 minutes later, 0.3 mg/kg etomidate is injected within 30 to 60 s, and 90 s after the injection of etomidate, 0.2 mg/kg midazolam, 3 μg/kg fentanyl, 0.6 mg/kg rocuronium are given sequently.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group L3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Induction protocol: patients will be given 2 ml lidocaine injection in which 40 mg lidocaine is contained, 1 minutes later, 0.3 mg/kg etomidate is injected within 30 to 60 s, and 90 s after the injection of etomidate, 0.2 mg/kg midazolam, 3 μg/kg fentanyl, 0.6 mg/kg rocuronium are given sequently.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Hydrochloride Injection</intervention_name>
    <description>Lidocaine injection should be give before the injection of etomidate. In groups L1 and L2, 20 mg and 30 mg lidocaine injection will be diluted to 2ml separately.</description>
    <arm_group_label>Group L1</arm_group_label>
    <arm_group_label>Group L2</arm_group_label>
    <arm_group_label>group L3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Etomidate Fat Emulsion Injection</intervention_name>
    <description>1 minute after the injection of lidocaine, 0.3 mg/kg etomidate will be given in 30 to 60 s.</description>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_label>Group L1</arm_group_label>
    <arm_group_label>Group L2</arm_group_label>
    <arm_group_label>group L3</arm_group_label>
    <other_name>Fu Er Li</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>2 ml normal saline will be given 1 minute before the injection of etomidate in patients in group C, and in group L1 and L2, normal saline is used to dilute lidocaine injection to 2 ml.</description>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_label>Group L1</arm_group_label>
    <arm_group_label>Group L2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam Injection</intervention_name>
    <description>0.02 mg/kg midazolam will be given to the patients in all groups 90 s after the injection of etomidate.</description>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_label>Group L1</arm_group_label>
    <arm_group_label>Group L2</arm_group_label>
    <arm_group_label>group L3</arm_group_label>
    <other_name>Li Yue Xi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl Citrate Injection</intervention_name>
    <description>3 μg/kg fentanyl will be given to patients in all groups after the injection of midazolam.</description>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_label>Group L1</arm_group_label>
    <arm_group_label>Group L2</arm_group_label>
    <arm_group_label>group L3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rocuronium Injection</intervention_name>
    <description>0.6 mg/kg rocuronium will be given to patients in all groups after the injection of fentanyl.</description>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_label>Group L1</arm_group_label>
    <arm_group_label>Group L2</arm_group_label>
    <arm_group_label>group L3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1. Aged between 60 and 81 years 2. Body mass index: 20 to 30 kg/m2 3. American Society
             of Anesthesiology (ASA) Physical Status: Ⅰ or Ⅱ 4. Signed informed consent form

        Exclusion Criteria:

          -  1. Use of sedatives or opioids 2. History of central nervous system diseases, like
             epilepsy, shaking palsy, or chorea, etc 3. Hyperthyroidism 4. Serious diabetes 5.
             Hyperkalemia 6. Cardiac surgery 7. Serious ventricular disease or atrioventricular
             block 8. Liver or renal dysfunction 9. Allergies to amide local anesthetics or fat
             emulsion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>81 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yu Guo</last_name>
    <phone>+86-18009200936</phone>
    <email>guoyu986121@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>TangDu Hospital,FMMU</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu Guo</last_name>
      <phone>+86-18009200936</phone>
      <email>guoyu986121@163.com</email>
    </contact>
    <investigator>
      <last_name>Yu Guo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2014</study_first_submitted>
  <study_first_submitted_qc>May 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 19, 2014</study_first_posted>
  <last_update_submitted>May 16, 2014</last_update_submitted>
  <last_update_submitted_qc>May 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 19, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myoclonus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Etomidate</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

